Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




When Exercise Is Unhealthy: Study Sheds New Light on Sudden Cardiac Death

By LabMedica International staff writers
Posted on 30 Dec 1899
Researchers have discovered new aspects, involving a mutated protein, of a not-well-understood mechanism that underlies how sudden heart failure can occur during endurance exercise in patients with arrhythmogenic ventricular cardiomyopathy (AVC), which currently has no standardized guidelines for exercise management. More...
The findings may inform development of early diagnostics, drug treatments, and personalized exercise programs.

AVC is the most common heart condition that causes sudden cardiac death during intense exercise. Using various analyses of cardiac function and morphology, a team led by Jeffrey A. Towbin, MD, of the University of Tennessee Health Science Center (Memphis, TN, USA), in collaboration with researchers from Cincinnati Children’s Hospital Medical Center (Cincinnati, OH, USA) and others has found that in mice with a known mutated version of desmoplakin, a protein that helps maintain the structure of the heart wall, exercise made the heart walls come apart sooner, leading to earlier development of AVC.

Heart wall cells are stacked in interlocking layers attached to each other by desmosomes that dot the surface of the cells. Exercise can overstretch the heart wall, but these intercellular links keep the cells from disconnecting from each other and prevent the heart wall from coming apart. Desmosomes are made up of several proteins, including desmoplakin. Defects can weaken the cell-cell links, as in AVC, such that the cells do not withstand the extra stretch from exercise and so detach from each other. Scar tissue fills the gaps between the disconnected cells, further reducing the wall’s ability to withstand increased workload as in exercise.

Several studies observed that mice with a mutated form of desmoplakin developed the same heart problems seen in patients with AVC. In this new study, in addition to finding that endurance exercise led to earlier onset of AVC symptoms in the mice with the mutated desmoplakin, the researchers also discovered that the desmosomes started coming apart before changes in heart function were detected and that exercise perturbed AKT1 and GSK3-β signaling in the Wnt-β-catenin pathway, which promotes growth of new cells and prevents deposition of fat, offering an explanation for the accelerated development of AVC.

The study suggests that changes in the cell-cell links can be detected before alterations in heart function occur. This could help identify individuals with the mutation before they develop AVC symptoms, said Dr. Towbin, opening the possibility of better strategies to prevent exercise-induced complications and of developing drugs targeting the Wnt-β-catenin pathway to potentially help AVC patients.

The study, by Martherus R et al., was published online ahead of print November 6, 2015, in the American Journal of Physiology — Heart & Circulatory Physiology.

Related Links:

University of Tennessee Health Science Center
Cincinnati Children’s Hospital Medical Center



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Gold Member
Platelet Function Analyzer
PL-12
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The approach uses in-house pathology tests and streamlined access to specialists to shorten the diagnostic pathway for children with immune conditions. (Image Credit: iStock)

Streamlined Genetic Testing Speeds Pediatric Immune Disorder Diagnosis

Children with genetic immune conditions can develop life-threatening illness, unusual infections, or autoimmune problems before the underlying cause is identified. More than 500 of these rare disorders... Read more

Immunology

view channel
Image: Acute myeloid leukemia is the first of several disease areas the collaborators plan to pursue together as part of efforts to advance precision diagnostics (Image Credit: Adobe Stock)

Immune Profiling Initiative Aims to Improve Bone Marrow Analysis in Leukemia

Acute myeloid leukemia (AML) is an aggressive blood cancer in which assessing disease burden after therapy can help guide clinical evaluation. Patients with measurable residual disease (MRD) after treatment... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: The acquisition of Reveal Genomics would expand Hologic’s oncology diagnostics portfolio to support treatment decisions for more women with breast cancer.

Hologic to Broaden Breast Cancer Testing Portfolio Through Reveal Genomics Acquisition

Hologic (Marlborough, MA, USA) has signed a definitive agreement to acquire Reveal Genomics (Barcelona, Spain), a precision oncology company developing genomic diagnostic tests to help personalize cancer treatment.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.